American Capital Advisory’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41K Sell
22
-2
-8% -$131 ﹤0.01% 716
2026
Q1
$1.71K Sell
24
-3
-11% -$237 ﹤0.01% 566
2025
Q4
$2.21K Buy
27
+5
+23% +$390 ﹤0.01% 449
2025
Q3
$1.65K Buy
22
+7
+47% +$522 ﹤0.01% 454
2025
Q2
$1.11K Buy
15
+9
+150% +$627 ﹤0.01% 479
2025
Q1
$485 Sell
6
-1
-14% -$86 ﹤0.01% 521
2024
Q4
$548 Hold
7
﹤0.01% 436
2024
Q3
$657 Sell
7
-1
-13% -$84 ﹤0.01% 419
2024
Q2
$619 Hold
8
﹤0.01% 387
2024
Q1
$657 Hold
8
﹤0.01% 406
2023
Q4
$619 Buy
+8
New +$560 ﹤0.01% 387

Other funds holding GEHC

American Capital Advisory's GEHC Position: Q2 2026 in Review

American Capital Advisory reduced its GE HealthCare (GEHC) stake by 8.3% in Q2 2026, selling an estimated $131 and leaving 22 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

American Capital Advisory first reported a position in GEHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.21K in Q4 2025. 1,228 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • American Capital Advisory held 22 shares of GE HealthCare worth $1.41K as of Q2 2026.
  • American Capital Advisory sold 2 GE HealthCare shares in Q2 2026, an estimated $131.
  • GE HealthCare made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #716 holding.
  • American Capital Advisory first reported a position in GE HealthCare in Q4 2023 and has held it in 11 quarters since.
  • American Capital Advisory's GE HealthCare position peaked at $2.21K in Q4 2025.
  • 1,228 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.